(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
On March 18, 2014, Biozone Pharmaceuticals, Inc., a Nevada corporation merged into its wholly-owned subsidiary, Cocrystal Pharma, Inc., a Delaware corporation. As a result, the issuer's name is now Cocrystal Pharma, Inc. There was no change in outstanding capitalization. All common and preferred shareholders received the exact same number of shares of capital stock they previously owned, and all options and warrants were converted in the same manner. Pending approval from the Financial Industry Regulatory Authority, the issuer's common stock continues to trade under the prior BZNE symbol.
Cocrystal Pharma, Inc. |
By: | /s/ Gary Wilcox |
Name: Gary Wilcox | |
Title: Chief Executive Officer |